Shanghai Bio-heart Biological Technology Co., Ltd. Stock
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 HKD | +4.84% | -3.47% | -42.98% |
Sales 2023 | - | Sales 2024 * | 21M 2.9M 22.71M | Capitalization | 439M 60.68M 475M |
---|---|---|---|---|---|
Net income 2023 | -176M -24.31M -190M | Net income 2024 * | -59M -8.15M -63.8M | EV / Sales 2023 | - |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 20.9 x |
P/E ratio 2023 |
-4.32
x | P/E ratio 2024 * |
-7.52
x | Employees | 32 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 47.42% |
1 day | +4.84% | ||
1 week | -3.47% | ||
Current month | -14.47% | ||
1 month | -18.75% | ||
3 months | -34.12% | ||
6 months | -18.75% | ||
Current year | -42.98% |
Managers | Title | Age | Since |
---|---|---|---|
Li Wang
CEO | Chief Executive Officer | 55 | 14-07-17 |
Tao Cai
CHM | Chairman | 38 | 14-06-30 |
Yun Qing Wang
DFI | Director of Finance/CFO | 40 | 20-09-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Li Wang
CEO | Chief Executive Officer | 55 | 14-07-17 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 20-11-23 |
Xu Bo Lu
BRD | Director/Board Member | 44 | 20-11-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.95 | +4.84% | 51 200 |
24-04-24 | 1.86 | -3.12% | 124,500 |
24-04-23 | 1.92 | +3.23% | 25,800 |
24-04-22 | 1.86 | -2.11% | 51,300 |
24-04-19 | 1.9 | -3.55% | 74,900 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 04:09 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.98% | 57.8M | |
+12.46% | 128B | |
-10.58% | 10.66B | |
-0.39% | 8.55B | |
+13.14% | 7.1B | |
+25.58% | 5.06B | |
+6.89% | 3.4B | |
-1.23% | 3.08B | |
-11.96% | 2.11B | |
-7.25% | 2.03B |
- Stock Market
- Equities
- 2185 Stock